---
title: "Cardiff Oncology, Nerviano settle onvansertib rights lawsuit, seek dismissal with prejudice"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/298918658.md"
description: "Cardiff Oncology and Nerviano Medical Sciences have settled their lawsuit regarding global rights to onvansertib. Both parties agreed to a full mutual release of claims in the U.S. District Court for the Southern District of California. They plan to seek dismissal with prejudice under an amended 2017 exclusive license agreement."
datetime: "2026-09-14T12:31:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/298918658.md)
  - [en](https://longbridge.com/en/news/298918658.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/298918658.md)
generator: "portal-rs"
---

# Cardiff Oncology, Nerviano settle onvansertib rights lawsuit, seek dismissal with prejudice

-   Cardiff Oncology reached a settlement with Nerviano Medical Sciences tied to litigation over global rights to onvansertib. \* Both sides agreed to a full mutual release of claims in a U.S. District Court case in Southern District of California. \* The parties plan to seek dismissal of all claims with prejudice under an amended 2017 exclusive license agreement. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cardiff Oncology Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609140830PRIMZONEFULLFEED9826162) on September 14, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [CRDF.US](https://longbridge.com/en/quote/CRDF.US.md)

## Related News & Research

- [Cardiff Oncology Gets FDA Orphan Drug Designation for Onvansertib in CMML](https://longbridge.com/en/news/302603910.md)
- [Cardiff Oncology, Nerviano Medical Sciences expand onvansertib collaboration under amended license agreement](https://longbridge.com/en/news/298926023.md)
- [BE: Revenue rose 138% YoY as margins expanded and FY2026 guidance was raised again](https://longbridge.com/en/news/302787538.md)
- [GE Vernova Stock Is Taking a Hit – What's Driving the Selloff and What Wall Street Sees Next](https://longbridge.com/en/news/302747785.md)
- [TTM Technologies Q3 net income jumps 60% to $84.8 million; Q3 net sales rise 60% to $1.2 billion](https://longbridge.com/en/news/302693400.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**